Abstract:Proc Amer Assoc Cancer Res, Volume 45, 2004 2314 Background: Oral Contraceptives (OCs) contain a potent synthetic estrogen, ethinyl estradiol (EE), possibly increasing breast cancer risk. However, prior investigations have found that little evidence of an OC and breast cancer association. OCs actually suppress endogenous E2 and are weak progenitors of reactive semi-quinone estrogen metabolites capable of damaging DNA, potentialy decreasing risk. NAD(P)H:-oxoreductase (NQO1) prevents genetic damage from reactive estrogens, but NQO1 induction also is regulated in part by the estrogen receptor (ER). Thus, the association between OC use and breast cancer may be complex, and depend on NQO1 activity and response to reactive oxygen species. Methods : A population-based case-control study in Shanghai, China. Cases were identified from the Shanghai Cancer Registry, and controls were identified using the population registry. OC history and other risk factors were assessed by questionnaire. Data from 1020 cases and 1095 controls were analyzed with logistic regression, controlling for age, BMI, and other risk factors. The NQO1 C609T polymorphism has limited activity compared to the C/C wild-type. Findings : Breast cancer was not directly associated with OC use or NQO1 genotypes. However, OC use increased postmenopausal breast cancer risk among women with the NQO1 C/C genotype (OR=2.03 (1.08, 3.80)), while a lower risk was observed with the T-allele of NQO1 (OR=0.70 (0.48, 1.04); pint <0.01). This crossover modification was stronger with OC use prior to age 30 years (C/C: OR=3.03 (1.42, 6.40)); C/T or T/T: OR=0.49 (0.29, 0.82), pint < 0.01). First OC use after age 30 years was associated with reduced premenopausal breast cancer (OR=0.52 (0.30,0.90)), and this association was restricted to women with the NQO1 T-allele (OR=0.39 (0.18, 0.82)). Interpretation : Prior research has found little consistent evidence for an association between OC use and breast cancer risk. Our results suggest that the OC and breast cancer association depends the age of OC use and NQO1 genotype, consistent with E2 suppression and the ability to invoke an adequate protective response to reactive semi-quinone estrogen metabolties previously linked with breast carcinogenesis. View this table:

Low Plasma Coenzyme Q10 Levels and Breast Cancer Risk in Chinese Women

Plasma Carotenoids, Tocopherols, Retinol and Breast Cancer Risk: Results from the Shanghai Women Health Study (SWHS)

Abstract B88: Plasma carotenoids, tocopherols, retinol and breast cancer risk: Results from the Shanghai Women's Health Study

A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer

Plasma Sex Steroid Hormones and Breast Cancer Risk in Chinese Women

Association of Coenzyme Q10 with Premature Ovarian Insufficiency

Higher Blood 25(OH)D Level May Reduce the Breast Cancer Risk: Evidence from a Chinese Population Based Case-Control Study and Meta-Analysis of the Observational Studies

Oral contraceptives and breast cancer risk: Modification by NQO1genetic polymorphisms.

Circulating Adiponectin And Risk Of Endometrial Cancer

Oral Contraceptive Use and Breast Cancer Risk: Modification by NAD(P)H:quinone Oxoreductase (NQO1) Genetic Polymorphisms.

Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women

Correlates of 25-Hydroxyvitamin D among Chinese Breast Cancer Patients.

The Effect of Coenzyme Q10 Supplementation on Vascular Endothelial Growth Factor and Serum Levels of Interleukin 6 and 8 in Women with Breast Cancer: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Energy Balance, Insulin Resistance Biomarkers, and Breast Cancer Risk.

Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women

Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.

Soy Intake and Breast Cancer Risk: a Prospective Study of 300,000 Chinese Women and a Dose-Response Meta-Analysis.

Dietary Polyunsaturated Fatty Acids and Breast Cancer Risk in Chinese Women: A Prospective Cohort Study

Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.

Analysis of plasma and erythrocyte zinc levels in premenopausal women with breast cancer

Associations between Long-Term Dietary Coenzyme Q10 Intake and New-Onset Hypertension in Adults: Insights from a Nationwide Prospective Cohort Study